The Society for Cardiovascular Angiography and Interventions offers its top five key takeaways from the EuroPCR 2024 meeting last week.

Cardiologist Jerry Blackwell, MD, president and CEO of MedAxiom, believes cardiologist can't just focus on clinical decisions, as they also must be aware the financial ramifications. 

The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care. 

One of the biggest decisions in a cardiologist's life is knowing when, exactly, to start a family. Nandita S. Scott, MD, co-director of the Corrigan Women's Heart Health Program at Mass General Hospital, shared her perspective on this important topic. 

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results. 

Researchers tracked data from more than 7,500 patients, sharing their findings at EuroPCR 2024 in Paris and in JSCAI.

Vaccination was linked to key benefits in terms of all-cause mortality, heart failure hospitalizations, stroke, heart attack, myocarditis, venous thromboembolism and testing positive for COVID-19. 

The fifth-generation valve is associated with improved hemodynamic data and a reduced rate of paravalvular leak, according to new research published in JACC: Cardiovascular Interventions and EuroIntervention.